Balthasar L Hug
Affiliation: University Hospital
- Use of hepatotoxic drugs in chronic liver diseaseBalthasar L Hug
Division of Internal Medicine, Basel University Hospital, Basel, Switzerland
J Patient Saf 8:45-50. 2012..In the future, pharmacogenomics and electronic linking of clinical data may well prove helpful for making decisions about optimal drug choices in this complex group of patients...
- [Nosocomial urinary tract infection in adults]B L Hug
Medizinische Klinik, Universitatsspital Basel, Basel, Schweiz
Internist (Berl) 47:1151-62. 2006..Comorbidities should be considered and potential obstructions of urinary flow removed. Economically important are the normally higher prices of i.v. antibiotics compared to oral use...
- [Somnolence of unknown origin--illness or drug problem?]B L Hug
Medizinische Klinik B, Universitatsspital Basel
Ther Umsch 63:773-6. 2006..It is important to realize that three out of four ADEs are estimated to be preventable...
- Individualising drug dispensaries in a university hospitalBalthasar L Hug
Department of Internal Medicine, University Hospital, CH 4031 Basel, Switzerland
Swiss Med Wkly 137:62-5. 2007..The interdisciplinary intervention described here took place on three 40-bed wards in a 700-bed university hospital housing patients in general internal medicine, haematology, nephrology and oncology...
- Mortality and drug exposure in a 5-year cohort of patients with chronic liver diseaseB L Hug
Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
Swiss Med Wkly 139:737-46. 2009..Chronic liver diseases are common in the general population. Drug treatment in this group may be challenging, as many drugs are hepatically metabolised and hepatotoxic...
- Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidneyBalthasar L Hug
Division of General Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120 1613, USA
Kidney Int 76:1192-8. 2009..Our study shows that ADEs were common in patients with impaired kidney function in community hospitals, and many appear potentially preventable with renal dose checking...
- Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for preventionBalthasar L Hug
Division of General Internal Medicine, Brigham and Women s Hospital, Brigham Circle, 1620 Tremont St, 3rd Floor, Boston, MA, 02120 1613, USA
J Gen Intern Med 25:31-8. 2010..Medications represent a major cause of harm and are costly for hospitalized patients, but more is known about these issues in large academic hospitals than in smaller hospitals...
- The costs of adverse drug events in community hospitalsBalthasar L Hug
Division of General Internal Medicine, Brigham and Women s Hospital, Boston, USA
Jt Comm J Qual Patient Saf 38:120-6. 2012....
- Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University HospitalMarkus L Lampert
Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy, University of Basel, Basel, Switzerland
Pharm World Sci 30:768-76. 2008..To evaluate the Pharmaceutical Care Network Europe (PCNE) classification system as a tool for documenting the impact of a hospital clinical pharmacology service...